TP53 and pancreatic neoplasm: Considering that approximately 20% of p53-proficient human pancreatic cancer SW1990 cells undergo cell death under the same experimental conditions [26], it is suggestive that Panc-1 cells are much more resistant to GEM relative to SW1990 cells.